Cleared Traditional

K981338 - LD-1

K981338 is an FDA 510(k) clearance for LD-1, manufactured by Abbott Laboratories. The device is a Class 2 Chemistry device with product code JGF cleared through the Traditional 510(k) pathway after a 35-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1998
Decision
35d
Days
Class 2
Risk

K981338 is an FDA 510(k) clearance for the LD-1. Classified as Differential Rate Kinetic Method, Lactate Dehydrogenase Isoenzymes (product code JGF), Class II - Special Controls.

Submitted by Abbott Laboratories (Irving, US). The FDA issued a Cleared decision on May 18, 1998 after a review of 35 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1445 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K981338

510(k) Number K981338 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 13, 1998
Decision Date May 18, 1998
Days to Decision 35 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
53d faster than avg
Panel avg: 88d · This submission: 35d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JGF Device Classification - Class 2, Special Controls

Product Code JGF Differential Rate Kinetic Method, Lactate Dehydrogenase Isoenzymes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1445
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JGF Differential Rate Kinetic Method, Lactate Dehydrogenase Isoenzymes

Devices cleared under the same product code (JGF) and FDA review panel - the closest regulatory comparables to K981338.
ABBOTT QUICKSTART LD-1, MODIFICATION
K925188 · Em Diagnostic Systems, Inc. · Feb 1993
ABBOTT QUICKSTART LD-1,#5A30
K914261 · Em Diagnostic Systems, Inc. · Oct 1991
LD1 ISOENZYME REAGENT KIT
K890996 · Trace Scientific , Ltd. · May 1989
ABBOTT A-GENT LD-1 ISOZYME REAGENT
K871240 · Abbott Laboratories · May 1987
MAGNESIUM (SUBSTRATE, ENZYME, REAGENT)
K860367 · Alpkem Corp. · Apr 1986